Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer Patients
Phase of Trial: Phase IV
Latest Information Update: 04 May 2017
At a glance
- Drugs Paclitaxel (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 01 May 2017 Status changed from active, no longer recruiting to completed.
- 24 Oct 2016 Planned End Date changed from 1 Aug 2016 to 1 Dec 2021.
- 24 Oct 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Dec 2016.